Arecor Therapeutics plc (AIM:AREC)
London flag London · Delayed Price · Currency is GBP · Price in GBX
77.50
-6.50 (-7.74%)
Oct 7, 2025, 3:16 PM GMT+1

Arecor Therapeutics Revenue

Arecor Therapeutics had revenue of 2.00M GBP in the half year ending June 30, 2025, with 20.01% growth. This brings the company's revenue in the last twelve months to 5.06M, up 3.31% year-over-year. In the year 2024, Arecor Therapeutics had annual revenue of 5.05M with 10.50% growth.

Revenue (ttm)
5.06M
Revenue Growth
+3.31%
P/S Ratio
6.27
Revenue / Employee
115.02K
Employees
44
Market Cap
31.72M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20245.05M480.00K10.50%
Dec 31, 20234.57M2.17M90.30%
Dec 31, 20222.40M1.25M107.51%
Dec 31, 20211.16M-540.00K-31.80%
Dec 31, 20201.70M-192.99K-10.21%
Dec 31, 2019 Pro Pro Pro
May 31, 2019 Pro Pro Pro
May 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca41.24B
GSK plc31.63B
Haleon11.02B
Smith & Nephew4.33B
ConvaTec Group1.72B
Hikma Pharmaceuticals2.35B
HUTCHMED (China)439.54M
Genus672.80M
Revenue Rankings